BioSpace News Archive

US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit lacted in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.

BIOTRONIK, a global leader in the treatment of cardiac and vascular disease is pleased to announce the first patient enrollment in BIO-CONDUCT, an FDA approved investigational device exemption (IDE) trial examining the use of the BIOTRONIK Solia S pacing lead when implanted in the left bundle branch (LBB) area, a location for which the Solia S lead is not currently approved.

Essent Biologics™, a leading supplier of human-derived cell and scaffold materials, announced availability of its Micronized Bone Matrix for 3D bioprinting and tissue engineering applications.

Tactical Therapeutics, Inc., a clinical stage biopharma, has been selected to present at the MedInvest Oncology Investor Conference taking place December 14-15, 2022, in New York, N.Y.

Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases and a vision of creating pan-respiratory vaccines for older adults, today provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against Respiratory Syncytial Virus (RSV).

Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), and GRI Bio, Inc. (“GRI Bio”) today announced that they have entered into a definitive agreement (the “Merger Agreement”) pursuant to which GRI Bio will merge with a wholly-owned subsidiary of Vallon in an all-stock transaction (the “Merger”).

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference.

Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company expects to receive CLIA certification in during first quarter 2023.

LiVeritas Biosciences, Inc. announced the opening of a software development subsidiary in Manila, Philippines, dedicated to the development of rapid-turnaround mass spectrometry analytics and machine learning tools.

NeurOptics’ Neurological Pupil index™ and automated pupillometry are now included in the updated 2021 European Resuscitation Council and European Society of Intensive Care Medicine Guidelines for post-resuscitation care as an objective measurement supporting neurological prognosis in patients following cardiac arrest.